RCGP Drug & Alcohol Misuse Training Programme, RCGP Sex, Drugs and HIV Task Group, SMMGP. (2004) Guidance for the use of buprenorphine for the treatment of opioid dependence in primary care. London: Royal College of General Practitioners.
Preview | Title | Contact |
---|---|---|
|
PDF (Guidance for the use of buprenorphine)
- Published Version
179kB |
External website: http://www.rcgp.org.uk/professional_development/su...
This guidance draws on the international research literature. It is recognised that this is a developing evidence base, and that this update incorporates new evidence since the guidance was first published in 2003. Further updates will also be required as there are some areas of clinical practice with buprenorphine for which, up to now, there is limited or no direct evidence available.
To address these evidence gaps, this document draws upon the clinical experience of experts in the field from primary and secondary care, involving discussion with international2 and national colleagues3. It also draws upon parallels from conventional methadone practice.
B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
HJ Treatment or recovery method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Community-based treatment (primary care)
VA Geographic area > International
Repository Staff Only: item control page